Found: 107
Select item for more details and to access through your institution.
Induction of Immune Reaction in Benign Melanocytic Nevi Without Halo During Nivolumab Therapy in a Patient With Melanoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 457, doi. 10.1007/s00432-019-03072-1
- By:
- Publication type:
- Article
Development of a video image-based QA system for the positional accuracy of dynamic tumor tracking irradiation in the Vero4DRT system.
- Published in:
- Medical Physics, 2015, v. 42, n. 8, p. 4745, doi. 10.1118/1.4926779
- By:
- Publication type:
- Article
Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11578-x
- By:
- Publication type:
- Article
Small cell lung carcinoma initially presenting as giant left ventricular mass.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 3, p. 359, doi. 10.1093/jjco/hyad173
- By:
- Publication type:
- Article
54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1723, doi. 10.1093/jjco/hyab154
- By:
- Publication type:
- Article
Synchronous dilemma of sarcoid-like reaction and drastic response after PD-1 blockade administration in lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 7, p. 1179, doi. 10.1093/jjco/hyab043
- By:
- Publication type:
- Article
dose-finding randomized Phase II study of oral netupitant in combination with palonosetron.75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 2, p. 121, doi. 10.1093/jjco/hyy161
- By:
- Publication type:
- Article
Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 367, doi. 10.1093/jjco/hyy016
- By:
- Publication type:
- Article
Systemic CD4 immunity: A powerful clinical biomarker for PD‐L1/PD‐1 immunotherapy.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 9, p. 1, doi. 10.15252/emmm.202012706
- By:
- Publication type:
- Article
Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer.
- Published in:
- Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00538-x
- By:
- Publication type:
- Article
Value of <sup>18</sup>F-FDG-PET to predict PD-L1 expression and outcomes of PD-1 inhibition therapy in human cancers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical Issue of Myasthenia Gravis Related to Immune Checkpoint Inhibitors.
- Published in:
- Current Oncology Reports, 2024, v. 26, n. 9, p. 1113, doi. 10.1007/s11912-024-01571-0
- By:
- Publication type:
- Article
Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Progression to Lymph Node Metastasis After Spontaneous Regression of Pulmonary Adenocarcinoma Following Biopsy.
- Published in:
- In Vivo, 2024, v. 38, n. 3, p. 1498, doi. 10.21873/invivo.13597
- By:
- Publication type:
- Article
Membranous Nephropathy as a Paraneoplastic Syndrome in Cancer of Unknown Primary.
- Published in:
- In Vivo, 2024, v. 38, n. 3, p. 1503, doi. 10.21873/invivo.13598
- By:
- Publication type:
- Article
Occurrence of Hematological Malignancy in Long-term Survivors With Advanced Thymic Cancer.
- Published in:
- In Vivo, 2020, v. 34, n. 3, p. 1511, doi. 10.21873/invivo.11938
- By:
- Publication type:
- Article
Severe Thrombocytopenia Associated With Pembrolizumab in Patients With Non-small Cell Lung Cancer (NSCLC): A Case Report and Literature Review.
- Published in:
- In Vivo, 2020, v. 34, n. 2, p. 877, doi. 10.21873/invivo.11852
- By:
- Publication type:
- Article
Metachronous lesions in the orbit, retroperitoneum, and pleura of mucosa‐associated lymphoid tissue lymphoma: A case report.
- Published in:
- Cancer Reports, 2022, v. 5, n. 10, p. 1, doi. 10.1002/cnr2.1689
- By:
- Publication type:
- Article
Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 3, p. 725, doi. 10.3390/jcm9030725
- By:
- Publication type:
- Article
Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-27237-0
- By:
- Publication type:
- Article
Case Report: A Case of Renal Cell Carcinoma Unclassified With Medullary Phenotype Exhibiting a Favorable Response to Combined Immune Checkpoint Blockade.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.934991
- By:
- Publication type:
- Article
Henoch Schönlein purpura associated with pulmonary adenocarcinoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase II study of daily carboplatin plus irradiation followed by durvalumab for stage III non-small cell lung cancer patients with PS 2 up to 74 years old and patients with PS 0 or 1 from 75 years: NEJ039A (trial in progress).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1066, doi. 10.1007/s10637-022-01269-9
- By:
- Publication type:
- Article
A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016).
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 227, doi. 10.1007/s10637-017-0436-1
- By:
- Publication type:
- Article
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 2, p. 124, doi. 10.1007/s10147-023-02445-4
- By:
- Publication type:
- Article
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non-Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Simultaneous development of Graves' disease and type 1 diabetes during anti‐programmed cell death‐1 therapy: A case report.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 4, p. 1006, doi. 10.1111/jdi.13212
- By:
- Publication type:
- Article
Eradication of established murine skin tumors by cyclic chemoimmunotherapy with cyclophosphamide and effector T cells.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Eradication of Established Murine Skin Tumors by Cyclic Chemoimmunotherapy with Cyclophosphamide and Effector T Cells.
- Published in:
- Middle East Journal of Cancer, 2011, v. 2, n. 1, p. 9
- By:
- Publication type:
- Article
Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with EGFR mutations (Heat on Beat study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920967254
- By:
- Publication type:
- Article
Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01606-7
- By:
- Publication type:
- Article
Correction: Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment.
- Published in:
- Breast Cancer Research, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13058-023-01606-7
- By:
- Publication type:
- Article
DDX3X Induces Primary EGFR-TKI Resistance Based on Intratumor Heterogeneity in Lung Cancer Cells Harboring EGFR-Activating Mutations.
- Published in:
- 2014
- By:
- Publication type:
- Abstract
mTOR Inhibitors Control the Growth of EGFR Mutant Lung Cancer Even after Acquiring Resistance by HGF
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0062104
- By:
- Publication type:
- Article
The Effects of All-Trans Retinoic Acid on the Induction of Oral Tolerance in a Murine Model of Bronchial Asthma.
- Published in:
- International Archives of Allergy & Immunology, 2015, v. 167, n. 3, p. 167, doi. 10.1159/000437326
- By:
- Publication type:
- Article
Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Contraction and intracellular calcium-ion elevation of cultured human aortic smooth muscle cells by endothelin-1, vasoactive intestinal contractor (VIC) and the derivatives.
- Published in:
- In Vitro Cellular & Developmental Biology Animal, 1997, v. 33, n. 10, p. 751, doi. 10.1007/s11626-997-0153-8
- By:
- Publication type:
- Article
Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 3, p. 1, doi. 10.1007/s00262-024-03629-1
- By:
- Publication type:
- Article
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1619, doi. 10.1007/s00262-013-1467-x
- By:
- Publication type:
- Article
Vaccination with CD133 melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 11, p. 1597, doi. 10.1007/s00262-011-1063-x
- By:
- Publication type:
- Article
Advanced Research on Immune Checkpoint Inhibitor Therapy.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 18, p. N.PAG, doi. 10.3390/jcm11185392
- By:
- Publication type:
- Article
Effect of Systemic Steroid Use for Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Receiving PD-1 Blockade Drugs.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3744, doi. 10.3390/jcm10163744
- By:
- Publication type:
- Article
Clinical Outcome of Nivolumab Plus Ipilimumab in Patients with Locally Advanced Non-Small-Cell Lung Cancer with Relapse after Concurrent Chemoradiotherapy followed by Durvalumab.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1409, doi. 10.3390/cancers16071409
- By:
- Publication type:
- Article
Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2846, doi. 10.3390/cancers14122846
- By:
- Publication type:
- Article